慣性聚合 高效追讀感興趣之博客、新聞、科技資訊
閱原文 以慣性聚合開啟

推薦訂閱源

博客园 - 司徒正美
V
V2EX
T
Tailwind CSS Blog
有赞技术团队
有赞技术团队
aimingoo的专栏
aimingoo的专栏
Apple Machine Learning Research
Apple Machine Learning Research
IT之家
IT之家
Blog — PlanetScale
Blog — PlanetScale
A
About on SuperTechFans
月光博客
月光博客
T
The Blog of Author Tim Ferriss
宝玉的分享
宝玉的分享
Martin Fowler
Martin Fowler
博客园 - 聂微东
The GitHub Blog
The GitHub Blog
V
Visual Studio Blog
WordPress大学
WordPress大学
酷 壳 – CoolShell
酷 壳 – CoolShell
Engineering at Meta
Engineering at Meta
GbyAI
GbyAI

DEV Community

Authentication Security Deep Dive: From Brute Force to Salted Hashing (With Java Examples) Why AI Systems Don’t Fail — They Drift Spilling beans for how i learn for exam😁"Reinforcement Learning Cheat Sheet" I Replaced Chrome with Safari for AI Browser Automation. Here's What Broke (and What Finally Worked) How Python Borrows Other People's Work The $40 Architecture: Processing 1 Billion API Requests with 99.99% Uptime Vibe Coding: A Workflow Guide (From Zero to SaaS) Most webhook security guides protect the wrong side. The scary part is delivery. Headless CMS for TanStack Start: Build a Blog with Cosmic EU Age Verification App "Hacked in 2 Minutes" — What Actually Happened Comfy Cloud’s delete function does not actually remove files Running AI Models on GPU Cloud Servers: A Beginner Guide Event-driven media intelligence with AWS Step Functions and Bedrock I scored 500 AI prompts across 8 quality dimensions — here's what broke How to Call Google Gemini API from Next.js (Free Tier, No Backend Needed) The Portal Protocol: Reclaiming Human Connection in the Age of AI How to Fix Your Team's Scattered Knowledge Problem With a Self-Hosted Forum Intro to tc Cloud Functors: A Graph-First Mental Model for the Modern Cloud Designing Multi-Tenant Backends With Both Ownership and Team Access I Built a Neumorphic CSS Library with 77+ Components — Here's What I Learned PostgreSQL Performance Optimization: Why Connection Pooling Is Critical at Scale Cómo construí un SaaS multi-rubro para gestionar expensas en Argentina con FastAPI + Vue 3 🚀 I Built an Ethical Hacking Scanner Tool – Open Source Project I Replaced /usage and /context in Claude Code With a Single Statusline A Pythonic Way to Handle Emails (IMAP/SMTP) with Auto-Discovery and AI-Ready Design I Collected 8.9 Million Polymarket Price Points — Here's What I Found About How Markets Really Move EcoTrack AI — Carbon Footprint Tracker & Dashboard Everyone's Using AI. No One Agrees How. 5 self-hosted ebook managers worth trying in 2026 Building Your First AI Agent with LangChain: From Chatbot to Autonomous Assistant Common SOC 2 Failures (Real World) Stop Vibe-Checking Your AI App: A Practical Guide to Evals How to Use SonarQube and SonarScanner Locally to Level Up Your Code Quality Your Next To-Do App Is Dead — I Replaced Mine with an OpenClaw AI Sign a Nostr event in 60 lines of Python using coincurve — no nostr-sdk, no nbxplorer, no rust toolchain ITGC Audit Explained Like You’re in Big 4 Patch Tuesday abril 2026: Microsoft parcha 163 vulnerabilidades y un zero-day en SharePoint Stop scraping everything: a better way to track competitor price changes Listing on MCPize + the Official MCP Registry while routing payments OUTSIDE the marketplace — how I kept 100% of my x402 revenue Building an AI-Powered Risk Intelligence System Using Serverless Architecture Why We Ripped Function Overloading Out of Our AI Toolchain Testing AI-Generated Code: How to Actually Know If It Works SaaS Churn Is Killing Your Business. Here Is What to Do About It (Without a Support Team) The Speed of AI Is No Longer Linear - And Self-Improving Models Are Why How to Implement RBAC for MCP Tools: A Practical Guide for Engineering Teams From Standard Quote to Persuasive Proposal: AI Automation for Arborists I built a CLI that scaffolds complete multi-tenant SaaS apps Axios CVE-2025–62718: The Silent SSRF Bug That Could Be Hiding in Your Node.js App Right Now The dashboard that ended our friendship Data Pipelines Explained Simply (and How to Build Them with Python)
YMYL:当Google以更高标准要求你之时
Joseph Anady · 2026-05-24 · via DEV Community

初载于thatdevpro.com.此乃ThatDevPro公开SEO+AI框架库之部分。ThatDevPro乃经SDVOSB认证之退伍军人创办之网络+AI工程之坊。开源AI引证之具:github.com/Janady13/aio-surfaces


尔财或尔命——内容敏感度分类 & 高风险品质标准

详尽之安装与稽核指南,用以辨析网站之 YMYL 内容,施以 Google 所求之高格标准,并护佑用户与商家,免于 YMYL 违规所引法律、规约及排名之祸。此文双用:安装手册,稽核文书.

跨栈实施之注记:此框架中代码示例,皆以素HTML书之,以明其理。若React、Vue、Svelte、Next.js、Nuxt、SvelteKit、Astro、Hugo、11ty、Remix、WordPress、Shopify、Webflow诸般,其下每一范式之对应,详见于framework-cross-stack-implementation.md。若纯客户端渲染之SPA(无SSR/SSG),则参framework-react.md。若Tailwind特有之虑(清理、动态类、暗黑模式CLS、聚焦可及),则观framework-tailwind.md


一. 文档宗旨 & 本文档如何使用

一.一 此文档为何物

此乃谷歌之YMYL框架下分类网站内容之正宗参照,亦为实施YMYL内容所需之高规格标准。谷歌所视YMYL之每一类目,尽录于此。谷歌搜索质量评定者所寻YMYL内容之每一信号,皆明示之。凡满足YMYL标准所需之代码块、模式、结构要件,悉备于此.

1.2 三种运行模式

模式甲—安装模式:于新址或既有之址,构建符合 YMYL 之设施。依序循第 2 至第 17 节。

模式乙—审计模式:审既有之址,辨 YMYL 之分类与合规。越至第 12 节。

模式丙—混合模式:先审后装,于不合规者施之。

1.3 Claude Code CLI 之如何用此文

  1. 读第2节 — 汇集诸客户端变量,尤须明 YMYL 类别之决断
  2. 运第3节 — 以 YMYL 分类之决断树,辨网站或每页之 YMYL 状态
  3. 察既有之状 — 检视 YMYL 信赖要素已存何物
  4. 须依序循阶 — 普适根基先于内容殊异之要素
  5. 每阶既毕,宜验之
  6. 成报告 — 第十七节

1.4 纠纷调处之则

纠纷
既有之医法财之辩明 稽核以备周全。增补阙遗。未经法律审阅,勿删既有免责之辞。
既存评审之誉 核验评审者之资历。惟评审者有更易,方予更新。
现行编撰之规约页 稽核五二九条之要。补遗要素。存定制之宜。
既存更正之序 验之合乎规牍。载其参差,俟人手察之。
既有文牍,其分类异于此规。 标以人手察之,属法务/合规主事者。勿自更其类。

1.5 所需之具 & 验者

  • Whitespark / BrightLocal / Moz Local — 以考引文之序
  • PubMed — 以引医学之要文(健康 YMYL)
  • SEC EDGAR — 以引金融之要源(金融 YMYL)
  • Westlaw / LexisNexis / CourtListener — 以引法律之要据(法律 YMYL)
  • FTC.gov — 供广告/联盟披露合规参考
  • 各州检察官网站 — 各州特定隐私及消费者保护法
  • Originality.ai — 供AI内容检测(信任信号验证)

2. 客户变量采集

# ============================================
# YMYL FRAMEWORK CLIENT VARIABLES
# ============================================

# --- Business Classification (REQUIRED) ---
business_name: ""
primary_domain: ""
business_industry: ""
state_of_operation: ""               # Primary state — affects regulatory framework
states_served: []                    # All states where the business operates

# --- YMYL Classification (REQUIRED) ---
ymyl_overall_classification: ""      # "full_ymyl", "partial_ymyl", "lite_ymyl", "non_ymyl"
ymyl_categories: []                  # Categories applicable to this site:
                                     # "health_medical", "mental_health", "fitness_nutrition",
                                     # "financial_advice", "investing", "tax", "banking", "insurance",
                                     # "legal_advice", "civic_government", "elections",
                                     # "safety_personal", "safety_occupational",
                                     # "major_life_decisions", "news_current_events",
                                     # "shopping_ecommerce"

# --- Content Inventory (REQUIRED for audit) ---
total_content_pieces: 0
ymyl_content_pieces: 0
ymyl_content_percentage: 0.0
ymyl_content_types: []               # "articles", "calculators", "tools", "directories", etc.

# --- Author/Reviewer Credentials (REQUIRED for full YMYL) ---
primary_authors:
  - name: ""
    credentials: []                  # Required: degrees, licenses, board certifications
    license_number: ""               # Where applicable (medical, legal, financial)
    license_state: ""                # Where applicable
    license_verification_url: ""     # Public verification link
    years_practicing: 0
    specialty_areas: []
    conflicts_of_interest: []

medical_reviewers:                   # Required for health YMYL
  - name: ""
    credentials: []                  # MD, RN, NP, DO, PhD, etc.
    license_number: ""
    license_state: ""
    npi_number: ""                   # National Provider Identifier
    specialty: ""
    affiliations: []                 # Hospital systems, academic institutions

legal_reviewers:                     # Required for legal YMYL
  - name: ""
    bar_admission: []                # State(s) where admitted
    bar_number: ""
    practice_areas: []
    firm_affiliation: ""

financial_reviewers:                 # Required for finance YMYL
  - name: ""
    credentials: []                  # CFP, CFA, CPA, ChFC, RIA registration
    sec_registration: ""             # If applicable
    finra_crd: ""                    # If applicable
    state_registrations: []
    specialty: ""

# --- Compliance Posture (REQUIRED) ---
hipaa_applicable: false              # Health entities subject to HIPAA
ferpa_applicable: false              # Educational records
glba_applicable: false               # Financial services
sox_applicable: false                # Public companies
fcra_applicable: false               # Consumer reporting
finra_member: false                  # Securities-related
sec_registered: false                # Investment advisor
state_insurance_licensed: []         # States with insurance license
attorney_advertising_compliant: false # If legal services

# --- Editorial Process (REQUIRED) ---
has_editorial_policy: false
has_corrections_policy: false
has_fact_checking_process: false
fact_checking_methodology: ""        # Brief description
review_cadence: ""                   # "monthly", "quarterly", "biannually", "annually"
content_source_standards: ""         # "primary_only", "primary_plus_secondary", etc.

# --- Disclosures (REQUIRED) ---
has_medical_disclaimer: false
has_financial_disclaimer: false
has_legal_disclaimer: false
has_general_advice_disclaimer: false
has_advertising_disclosure: false
has_affiliate_disclosure: false
has_sponsored_content_disclosure: false
has_ai_use_disclosure: false
has_conflict_of_interest_disclosure: false
has_results_may_vary_disclaimer: false  # For testimonials/case studies

# --- AI Use in YMYL Content (REQUIRED) ---
uses_ai_in_ymyl_content: false
ai_review_protocol_for_ymyl: ""      # If true: must describe stricter review for YMYL specifically

# --- Existing Compliance Documentation ---
last_legal_review_date: ""
legal_counsel_firm: ""
last_compliance_audit_date: ""
known_compliance_gaps: []

进入全屏模式 退出全屏模式

变量既集,存之。ymyl-variables.yml于项目之根。


三、何谓 YMYL

YMYL即代表尔财或尔命 — 谷歌分类内容之谓,指不实、误导或低质之信息,能致用户身心、财货、安全、福祉于实害。此语肇于谷歌搜索质量评者指南,谓谷歌于此类题材,持内容之标准远超常类。

YMYL非别之排名因子,乃品質倍率 — 此分類者,使谷歌之算法與人類評者,於內容應用高標準之 E-E-A-T。非 YMYL 之文章,若 E-E-A-T 評審得 80%,或可名列前茅;而 YMYL 之文章,即便 80%,亦多困頓。此標準之所以更高者,蓋因 YMYL 內容之弊,其後果遠較尋常為烈也。

二零二五年九月搜索质量评审者指南之修订,大增 YMYL 类目,明纳选举、公民机构及政府信息于其中。与康健、财用、法度、安泰诸史类相并。此增扩,显Google于高风险民瘼议题上之谬误渐忧。论及此道之网域,今须恪守康健财用之高格。

YMYL施于之页。,非网站整体之谓也。通用博客或于众多非 YMYL 之文间刊一 YMYL 之文——此独文必合 YMYL 之格。主为 YMYL 之站(医事网站、金融顾问网站、法律目录)则几页皆须合 YMYL 之格。

失 YMYL 之四要果:

  1. 排名压制 — Google不优先展示未达标的医疗健康领域内容
  2. AI引擎去引用 — ChatGPT、Perplexity、Claude、Gemini避免引用不可信的医疗健康领域来源
  3. 监管行动 — 联邦贸易委员会、各州总检察长、专业许可委员会及证券监管机构均具执法权
  4. 民事责任 — 医事/法理/财事之非议,致人损害,则引法律之责

此规约明示辨识医理法理财理之内容,何者应持高标,及如何构建所须之信基


4. 医理法理财理之分类决树

4.1 主要医理法理财理之类别

以此树分类诸文。若任一枝回"有违公序良俗",则其文为"有违公序良俗".

Does the content cover any of the following?

├── Health & Medical
│   ├── Diagnosis or treatment of medical conditions → YMYL (health, full)
│   ├── Medication information, dosing, side effects → YMYL (health, full)
│   ├── Mental health advice or crisis information → YMYL (mental health, full)
│   ├── Nutrition advice with health claims → YMYL (health, partial)
│   ├── Fitness routines with injury risk → YMYL (health, partial)
│   ├── Supplements with medical claims → YMYL (health, full)
│   ├── Pregnancy, parenting infant care → YMYL (health, full)
│   ├── Veterinary medical advice → YMYL (health, partial)
│   └── General wellness lifestyle content → Non-YMYL (be cautious)
│
├── Financial
│   ├── Specific investment recommendations → YMYL (finance, full)
│   ├── Tax advice or strategy → YMYL (finance, full)
│   ├── Retirement planning advice → YMYL (finance, full)
│   ├── Loan/mortgage/credit advice → YMYL (finance, full)
│   ├── Insurance advice or comparisons → YMYL (finance, full)
│   ├── Cryptocurrency advice → YMYL (finance, full)
│   ├── General financial education → YMYL (finance, partial)
│   ├── Personal finance budgeting tips → YMYL (finance, partial)
│   └── Reviews of financial products → YMYL (finance, partial)
│
├── Legal
│   ├── Specific legal advice for situations → YMYL (legal, full)
│   ├── Court procedures and rights → YMYL (legal, full)
│   ├── Immigration guidance → YMYL (legal, full)
│   ├── Family law (divorce, custody) → YMYL (legal, full)
│   ├── Criminal law information → YMYL (legal, full)
│   ├── Estate planning/wills → YMYL (legal, full)
│   ├── Business legal information → YMYL (legal, partial)
│   ├── Legal directory listings → YMYL (legal, partial)
│   └── General "what is X law" reference → YMYL (legal, partial)
│
├── Civic & Government (expanded September 2025)
│   ├── Election information, voter rights → YMYL (civic, full)
│   ├── Government services and benefits → YMYL (civic, full)
│   ├── Public health information → YMYL (civic + health, full)
│   ├── Civic institutional information → YMYL (civic, full)
│   ├── Tax filing and government forms → YMYL (civic + finance, full)
│   └── Political opinion content → Non-YMYL (but information integrity matters)
│
├── Safety
│   ├── Personal safety (assault, abuse) → YMYL (safety, full)
│   ├── Occupational safety → YMYL (safety, full)
│   ├── Driving and vehicle safety → YMYL (safety, partial)
│   ├── Home safety (electrical, gas, structural) → YMYL (safety, partial)
│   ├── Drug/substance information → YMYL (safety + health, full)
│   ├── Outdoor/wilderness safety → YMYL (safety, partial)
│   └── Child safety → YMYL (safety, full)
│
├── Major Life Decisions
│   ├── Career changes and education → YMYL (significant)
│   ├── Relationship and divorce decisions → YMYL (significant)
│   ├── Major purchases (home, car) → YMYL (significant + finance)
│   ├── Adoption or fertility → YMYL (significant + health)
│   └── End-of-life planning → YMYL (significant + legal)
│
├── News & Current Events
│   ├── Breaking news with safety implications → YMYL (news, full)
│   ├── Investigative journalism → YMYL (news, full)
│   ├── Public health announcements → YMYL (news + health, full)
│   ├── Election coverage → YMYL (news + civic, full)
│   └── Entertainment news → Non-YMYL
│
└── E-Commerce
    ├── Health products, supplements → YMYL (lite + health-adjacent)
    ├── Financial products, insurance → YMYL (lite + finance-adjacent)
    ├── Safety equipment → YMYL (lite + safety-adjacent)
    ├── Children's products → YMYL (lite + safety-adjacent)
    └── General consumer goods → Non-YMYL (held to higher standards but not full YMYL)

进入全屏模式 退出全屏模式

4.2 分类层级释明

全为"有违公序良俗" — 甚高之标准适用。作者之资历须合乎主题之规约。每文必署审者之名。唯引首级文献。须有编务与更正之规。每文必列主题特有之免责声明。时效性内容每月更新之节奏.

部分涉及重大健康安全议题 — 标准虽高,然略有变通。需持证作者或审阅者。主源或优质次源皆可。须列免责声明。季度更新亦可。

Lite YMYL — 高于非 YMYL,然低于全 YMYL。非建议内容,持证作者为佳,非必。标准审阅程序。一般免责声明。季度更新。

非吾所求 — 规矩如常(详framework-eeat.md)。

4.3 特殊之境 与 之决断

个人之验 YMYL — "吾偿五十万之债"或"吾之化疗验"虽无正式之资,亦可贵为 YMYL 之文。视作 个人之验,非权威之见。须始终用第一人称。勿将个人之经历视为普适之建议。免责声明尤须明晰,此非专业之建议.

聚合之 YMYL — 乃聚诸内容之域(医者录、财货较),纵非其自撰,亦属 YMYL 之列。聚敛自当负 YMYL 之责——选辑之术,实左右用者之决也。

旨趣不明之文 — 未知之时,当以高者归类。视非吾所宜(non-YMYL)之内容为吾所宜(YMYL),其代价乃额外之严谨。视吾所宜(YMYL)之内容为非吾所宜(non-YMYL),其代价乃用户之潜在损害,加之排名之压制,复加监管之风险。

类别混杂之网站 — 诸域多兼载 YMYL 与非 YMYL 之文。唯以 YMYL 之则,施诸 YMYL 之页。宜使 YMYL 之文,与非 YMYL 之文,形貌有别,以助辨识(异其页式,明其审者之衔,显其免责之辞)。


5. YMYL 专章之施行要义

此节增补于标准E-E-A-T之安装。凡E-E-A-T之要求,犹存;而YMYL之内容,复须尽此节所载。

五一分阶段:YMYL库存&分類

安顿任何 YMYL 信赖要素之前,須分類其網站內容。

五分之一一之壹 内容审核脚本

每于其上之文:

  1. 观URL、页题、主旨
  2. 施第4.1節之決策樹
  3. 记 YMYL 分类:全 / 部 / 轻量级 / 无
  4. 记适用类目(如康健、财金、律法等)
  5. 察诸内容,若现时刊布,自诩权威之训,然无持证之作者,当予标识。

/admin/ymyl-inventory.csv处创制分类之表:

url,title,primary_topic,ymyl_classification,categories,current_author,author_credentials,reviewer,reviewer_credentials,disclaimer_present,citations_present,last_review_date,risk_level,action_required
/articles/diabetes-medication-guide,Diabetes Medication Guide,health/medication,full_ymyl,"health_medical","Sarah Smith","none","none","none","partial","2025-04-15","critical","add_medical_reviewer_disclaimer_citations"

入全景模式 出全景模式

五之一二 风险优先之补救次序

依风险之级排序库存:

  • 危殆之风险:无认证之作者/审阅者之 YMYL 内容,无免责声明,无引证之事实主张
  • 大风险: 缺少审阅者或免责声明之内容
  • 中风险新近之文,备诸要素,然陈旧矣。>岁杪更审十二月矣
  • 小风险内容合乎 YMYL 之规,然尚有微末增补之机

依序补救:危殆→高→中→低。危殆风险之 YMYL 内容,不可逾七日而未删。

五二第二阶段:编辑政策页

建哉/editorial-policy/此乃所有 YMYL 站点之必行也。

五二一 必备内容

<article class="editorial-policy">
  <h1>Editorial Policy</h1>

  <p>{{BUSINESS_NAME}} is committed to publishing accurate, helpful, and well-sourced content on topics that affect our readers' {{YMYL_CATEGORIES_PROSE}}. This editorial policy describes our content creation standards, review processes, and accountability mechanisms.</p>

  <h2>Our Authors and Reviewers</h2>
  <p>{{BUSINESS_NAME}} content is created and reviewed by individuals with verifiable credentials in their subject areas:</p>
  <ul>
    {{LIST_OF_AUTHORS_WITH_CREDENTIALS}}
    {{LIST_OF_REVIEWERS_WITH_CREDENTIALS}}
  </ul>
  <p>You can verify all author and reviewer credentials on their respective <a href="/authors/">author profile pages</a>.</p>

  <h2>Content Creation Process</h2>
  <ol>
    <li><strong>Topic selection:</strong> {{TOPIC_SELECTION_PROCESS}}</li>
    <li><strong>Research:</strong> {{RESEARCH_STANDARDS_PROSE}}</li>
    <li><strong>Drafting:</strong> {{DRAFTING_PROCESS_PROSE}}</li>
    <li><strong>Expert review:</strong> {{EXPERT_REVIEW_PROCESS_PROSE}}</li>
    <li><strong>Fact-checking:</strong> {{FACT_CHECKING_PROCESS_PROSE}}</li>
    <li><strong>Editorial review:</strong> {{EDITORIAL_REVIEW_PROCESS_PROSE}}</li>
    <li><strong>Publication:</strong> {{PUBLICATION_PROCESS_PROSE}}</li>
    <li><strong>Ongoing review:</strong> {{ONGOING_REVIEW_CADENCE_PROSE}}</li>
  </ol>

  <h2>Source Standards</h2>
  <p>For {{YMYL_CATEGORY}} content, we cite from primary sources:</p>
  <ul>
    {{IF_HEALTH}}<li>Peer-reviewed medical journals indexed in PubMed</li>{{/IF}}
    {{IF_HEALTH}}<li>FDA, NIH, CDC, and WHO official publications</li>{{/IF}}
    {{IF_FINANCE}}<li>SEC filings and EDGAR records</li>{{/IF}}
    {{IF_FINANCE}}<li>IRS publications and Treasury guidance</li>{{/IF}}
    {{IF_FINANCE}}<li>Federal Reserve, FDIC, and CFPB publications</li>{{/IF}}
    {{IF_LEGAL}}<li>Primary case law via Westlaw/LexisNexis/CourtListener</li>{{/IF}}
    {{IF_LEGAL}}<li>Federal and state statutes and regulations</li>{{/IF}}
    {{IF_LEGAL}}<li>Bar association ethics opinions</li>{{/IF}}
  </ul>

  <h2>Disclosures and Independence</h2>
  <p>{{BUSINESS_NAME}} maintains editorial independence. {{INDEPENDENCE_STATEMENT_PROSE}}</p>
  <p>When commercial relationships exist, they are disclosed at the article level. See our <a href="/disclosure/">full disclosures policy</a>.</p>

  <h2>Limitations and Disclaimers</h2>
  <p>Our content is informational and educational. {{TOPIC_SPECIFIC_DISCLAIMER_PROSE}}</p>
  <p>See: <a href="/medical-disclaimer/">Medical Disclaimer</a>, <a href="/financial-disclaimer/">Financial Disclaimer</a>, <a href="/legal-disclaimer/">Legal Disclaimer</a>.</p>

  <h2>Corrections and Updates</h2>
  <p>If you find an error in our content, please contact us. See our <a href="/corrections-policy/">Corrections Policy</a> for our process.</p>

  <h2>Contact</h2>
  <p>Editorial questions: <a href="mailto:editorial@{{PRIMARY_DOMAIN}}">editorial@{{PRIMARY_DOMAIN}}</a></p>
  <p>Last reviewed: <time datetime="{{LAST_REVIEW_DATE_ISO}}">{{LAST_REVIEW_DATE_HUMAN}}</time></p>
</article>

入全景模式 出全屏模式

五三阶段三:更正政策页

/corrections-policy/时构建。凡有 YMYL 站点皆须遵行。

<article class="corrections-policy">
  <h1>Corrections Policy</h1>

  <p>{{BUSINESS_NAME}} is committed to factual accuracy. When we publish errors, we correct them transparently.</p>

  <h2>How to Report an Error</h2>
  <p>If you find a factual error in any {{BUSINESS_NAME}} content, please contact us at <a href="mailto:corrections@{{PRIMARY_DOMAIN}}">corrections@{{PRIMARY_DOMAIN}}</a> with:</p>
  <ul>
    <li>The URL of the page containing the error</li>
    <li>The specific text or claim you believe is incorrect</li>
    <li>The correct information, with source if possible</li>
  </ul>

  <h2>Our Correction Process</h2>
  <ol>
    <li><strong>Acknowledge:</strong> We respond to correction requests within 2 business days.</li>
    <li><strong>Investigate:</strong> Our editorial team and (where applicable) subject matter expert reviewer evaluate the claim against primary sources.</li>
    <li><strong>Decide:</strong> If the claim is correct, we update the content. If we believe the original content was correct, we explain our reasoning.</li>
    <li><strong>Update:</strong> Corrections are made to the source content immediately.</li>
    <li><strong>Disclose:</strong> Material corrections are disclosed at the top of the article with the date of correction and the nature of the change.</li>
    <li><strong>Notify:</strong> If you reported the error, we follow up to inform you of the outcome.</li>
  </ol>

  <h2>Types of Corrections</h2>
  <dl>
    <dt>Material corrections</dt>
    <dd>Factual errors that change the meaning or recommendation of the content. These are disclosed at the top of the article and noted in our corrections log.</dd>

    <dt>Minor corrections</dt>
    <dd>Typos, grammatical errors, formatting issues. These are corrected silently.</dd>

    <dt>Updates</dt>
    <dd>Information that was correct at publication but has since changed (e.g., updated regulations). These are reflected via dateModified and noted in the article changelog.</dd>
  </dl>

  <h2>Corrections Log</h2>
  <p>We maintain a public log of all material corrections at <a href="/corrections-log/">/corrections-log/</a>.</p>

  <h2>Contact</h2>
  <p>Corrections: <a href="mailto:corrections@{{PRIMARY_DOMAIN}}">corrections@{{PRIMARY_DOMAIN}}</a></p>
</article>

全屏模式 退出全屏模式

配以/corrections-log/页,列明所有材料更正之日期、文章链接及更正性质。

五四阶段四:专题特定免责页

每 YMYL 类别需自具专有声明之页。

五、四、一、医者免责文/medical-disclaimer/— 为康健 YMYL

<article class="medical-disclaimer">
  <h1>Medical Disclaimer</h1>

  <p>The information provided on {{BUSINESS_NAME}} ({{PRIMARY_DOMAIN}}) is for general informational and educational purposes only. <strong>It is not a substitute for professional medical advice, diagnosis, or treatment.</strong></p>

  <h2>Always Seek Professional Medical Advice</h2>
  <p>Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website.</p>

  <h2>Emergency Situations</h2>
  <p><strong>If you think you may have a medical emergency, call 911 (or your local emergency number) or go to the nearest emergency room immediately.</strong></p>

  <p>If you are experiencing thoughts of suicide or self-harm:</p>
  <ul>
    <li>988 Suicide & Crisis Lifeline (US): Call or text 988</li>
    <li>Crisis Text Line: Text HOME to 741741</li>
    <li>International Association for Suicide Prevention: <a href="https://www.iasp.info/resources/Crisis_Centres/" rel="noopener">https://www.iasp.info/resources/Crisis_Centres/</a></li>
  </ul>

  <h2>No Doctor-Patient Relationship</h2>
  <p>Reading content on {{BUSINESS_NAME}} does not create a doctor-patient or healthcare provider relationship between you and {{BUSINESS_NAME}}, its authors, its medical reviewers, or anyone else affiliated with the site.</p>

  <h2>Individual Variation</h2>
  <p>Medical information presented on this site is general. Individual circumstances vary, and what is appropriate for one person may not be appropriate for another. Always consult with your healthcare provider before making decisions about your health.</p>

  <h2>Medications and Treatments</h2>
  <p>Information about medications, treatments, and procedures is for educational purposes. {{BUSINESS_NAME}} does not endorse or recommend any specific test, physician, product, procedure, opinion, or other information that may be mentioned on the site. Reliance on any information provided by {{BUSINESS_NAME}} is solely at your own risk.</p>

  <h2>Currency of Information</h2>
  <p>Medical knowledge evolves rapidly. While we work to keep our content current — see our <a href="/editorial-policy/">Editorial Policy</a> — information may not reflect the latest guidance. Always verify with your healthcare provider.</p>

  <h2>External Links</h2>
  <p>{{BUSINESS_NAME}} may contain links to external websites. We are not responsible for the content of those external sites and inclusion of a link does not constitute endorsement.</p>

  <h2>Editorial Standards</h2>
  <p>Our content is created by {{AUTHOR_DESCRIPTION}} and reviewed by licensed medical professionals. See our <a href="/editorial-policy/">Editorial Policy</a> for details.</p>

  <p><time datetime="{{LAST_UPDATED_ISO}}">Last updated: {{LAST_UPDATED_HUMAN}}</time></p>
</article>

入全景模式 出全屏模式

五、四、二、财務免責聲明/financial-disclaimer/)— 财务之 YMYL

<article class="financial-disclaimer">
  <h1>Financial Disclaimer</h1>

  <p>The information provided on {{BUSINESS_NAME}} ({{PRIMARY_DOMAIN}}) is for general informational and educational purposes only. <strong>It is not financial, investment, tax, or legal advice.</strong></p>

  <h2>No Personalized Advice</h2>
  <p>Nothing on this website constitutes a recommendation to buy, sell, or hold any security, investment, or other financial product. Content is general in nature and does not consider your specific financial situation, goals, or risk tolerance.</p>

  <h2>Consult Qualified Professionals</h2>
  <p>Before making financial decisions, consult with qualified professionals:</p>
  <ul>
    <li>Certified Financial Planner (CFP) for comprehensive financial planning</li>
    <li>Registered Investment Advisor (RIA) for investment advice</li>
    <li>Certified Public Accountant (CPA) or Enrolled Agent for tax advice</li>
    <li>Licensed insurance agent for insurance decisions</li>
    <li>Estate planning attorney for estate decisions</li>
  </ul>

  <h2>Past Performance Disclaimer</h2>
  <p><strong>Past performance is not indicative of future results.</strong> Investment values fluctuate, and you may lose principal. Historical examples shown for educational purposes do not guarantee similar future outcomes.</p>

  <h2>No Guarantees</h2>
  <p>{{BUSINESS_NAME}} makes no guarantees about the accuracy, completeness, timeliness, or applicability of information presented. Financial regulations, tax laws, and market conditions change frequently. Verify all information with current primary sources or qualified professionals.</p>

  <h2>Affiliate and Advertising Relationships</h2>
  <p>{{BUSINESS_NAME}} may have affiliate or advertising relationships with financial product providers. These relationships are disclosed at the article level. See our <a href="/disclosure/">full disclosures policy</a>. Such relationships do not influence editorial recommendations, but you should consider them when evaluating our content.</p>

  <h2>Securities Regulation Disclosure</h2>
  {{IF_NOT_REGISTERED_INVESTMENT_ADVISOR}}
  <p>{{BUSINESS_NAME}} is not a registered investment advisor under the Investment Advisers Act of 1940 and does not provide personalized investment advice. Information on this site is not tailored to any individual's financial situation.</p>
  {{/IF}}

  {{IF_REGISTERED_INVESTMENT_ADVISOR}}
  <p>{{BUSINESS_NAME}} is a Registered Investment Advisor (CRD #{{CRD_NUMBER}}). However, content on this website is for educational purposes and does not constitute personalized investment advice. Personalized advice is available only through our advisory engagement. <a href="/services/">Learn about our services</a>.</p>
  {{/IF}}

  <h2>Tax Disclaimer</h2>
  <p>Tax information is general and not personalized tax advice. Tax laws are complex and vary by jurisdiction and individual circumstances. Consult a qualified tax professional before making tax-related decisions.</p>

  <h2>No Fiduciary Relationship</h2>
  <p>Reading content on {{BUSINESS_NAME}} does not create a fiduciary or advisory relationship between you and {{BUSINESS_NAME}}.</p>

  <p><time datetime="{{LAST_UPDATED_ISO}}">Last updated: {{LAST_UPDATED_HUMAN}}</time></p>
</article>

入全景模式 退出全屏模式

5.4.3 法律免责声明(/legal-disclaimer/)—适用于法律要求的 YMYL

<article class="legal-disclaimer">
  <h1>Legal Disclaimer</h1>

  <p>The information provided on {{BUSINESS_NAME}} ({{PRIMARY_DOMAIN}}) is for general informational and educational purposes only. <strong>It is not legal advice.</strong></p>

  <h2>No Attorney-Client Relationship</h2>
  <p>Reading content on this website, contacting us through this website, or otherwise interacting with {{BUSINESS_NAME}} does not create an attorney-client relationship between you and {{BUSINESS_NAME}} or any of its authors, reviewers, or affiliates.</p>

  <p>An attorney-client relationship is established only through a signed engagement agreement.</p>

  <h2>Consult a Qualified Attorney</h2>
  <p>Laws vary by jurisdiction and change frequently. The information on this site may not be current or applicable to your specific situation. Always consult a qualified attorney licensed in your jurisdiction before making legal decisions.</p>

  <h2>Confidentiality</h2>
  <p><strong>Communications sent through this website are not confidential.</strong> Do not send confidential or time-sensitive information through this website or via email to addresses listed on this website.</p>

  <h2>No Guarantee of Outcome</h2>
  <p>Discussions of legal cases, statutes, or principles do not predict the outcome of any specific legal matter. Past results do not guarantee similar outcomes in your case.</p>

  <h2>Attorney Advertising</h2>
  {{IF_LAW_FIRM}}
  <p>This website may constitute attorney advertising under applicable rules of professional conduct. {{ATTORNEY_ADVERTISING_DISCLOSURE_BY_STATE}}.</p>
  {{/IF}}

  <h2>Bar Admissions</h2>
  {{IF_LAW_FIRM}}
  <p>{{BUSINESS_NAME}} attorneys are admitted to practice in the following jurisdictions: {{LIST_OF_BAR_ADMISSIONS}}. We do not practice law in jurisdictions where we are not admitted.</p>
  {{/IF}}

  <h2>Currency of Information</h2>
  <p>Laws change. Court decisions are issued daily. Regulations are updated. While we work to keep content current — see our <a href="/editorial-policy/">Editorial Policy</a> — information may not reflect the latest law. Always verify with current primary sources or a qualified attorney.</p>

  <h2>External Links</h2>
  <p>This website may link to external websites. We are not responsible for content on external sites, and inclusion of a link does not constitute endorsement.</p>

  <p><time datetime="{{LAST_UPDATED_ISO}}">Last updated: {{LAST_UPDATED_HUMAN}}</time></p>
</article>

进入全屏模式 退出全屏模式

5.5 第五阶段:每篇文章的 YMYL 信任要素

每篇 YMYL 文章除标准 E-E-A-T 要素外,皆需具备此等要素。

篇首声明横幅

<aside class="ymyl-top-disclaimer" role="note">
  <p>
    <strong>{{TOPIC_DISCLAIMER_HEADLINE}}</strong>
    {{TOPIC_DISCLAIMER_TEXT}}
    <a href="/{{TOPIC}}-disclaimer/">Read our full {{TOPIC}} disclaimer.</a>
  </p>
</aside>

全屏模式 退出全屏模式

例证:

关于健康:"此文仅为信息参考,非专业医疗建议之替代。凡涉个人医疗抉择,当咨询合格医疗提供者。"

於財務:此文僅供資訊參考,非個別財務諮詢。行財務決策前,請諮詢合格財務專業人士。

於法律:此文僅供資訊參考,非法律意見。涉及法律決策,請諮詢合格律師。

5.5.2 作者及審閱者功績區塊

<header class="article-header ymyl-article">
  <h1>{{TITLE}}</h1>

  <div class="ymyl-byline">
    <div class="author-credit">
      <img src="{{AUTHOR_PHOTO}}" alt="{{AUTHOR_NAME}}" width="48" height="48">
      <p>
        Written by <a href="/authors/{{AUTHOR_SLUG}}/" rel="author">{{AUTHOR_NAME}}</a>
        <br>
        <span class="credentials">{{AUTHOR_CREDENTIALS}}</span>
      </p>
    </div>

    <div class="reviewer-credit">
      <img src="{{REVIEWER_PHOTO}}" alt="{{REVIEWER_NAME}}" width="48" height="48">
      <p>
        {{REVIEWER_TYPE_VERB}} reviewed by <a href="/authors/{{REVIEWER_SLUG}}/">{{REVIEWER_NAME}}</a>
        <br>
        <span class="credentials">{{REVIEWER_CREDENTIALS}}</span>
        {{IF_LICENSED}}
        <br>
        <span class="license-info">License #{{LICENSE_NUMBER}}, {{LICENSE_STATE}} · <a href="{{VERIFY_URL}}" rel="noopener">Verify</a></span>
        {{/IF}}
      </p>
    </div>
  </div>

  <div class="ymyl-dates">
    <p>
      <time datetime="{{PUBLISHED_DATE}}">Published {{PUBLISHED_DATE_HUMAN}}</time>
      ·
      <time datetime="{{UPDATED_DATE}}">Last updated {{UPDATED_DATE_HUMAN}}</time>
      ·
      <time datetime="{{REVIEWED_DATE}}">Last reviewed by {{REVIEWER_TYPE}} {{REVIEWED_DATE_HUMAN}}</time>
    </p>
  </div>
</header>

入全屏模式 出全屏模式

{{REVIEWER_TYPE_VERB}}例:

  • "医者"(供医者审阅)
  • "律法"(供律者审阅)
  • "财计"(供财者审阅)

五五三 利害冲突之披露

当适用时:

<aside class="coi-disclosure" role="note">
  <strong>Conflict of Interest Disclosure:</strong>
  {{COI_DISCLOSURE_TEXT}}
</aside>

入全屏模式 退出全屏模式

例如:"作者持有本文所述公司之股份。审稿人曾为所提企业之一提供咨询。此等关系依本刊编辑政策披露,未影响所呈分析。"

5.5.4 主要文献引证

引据惟本源,注引须显链,直指原典文:

<p>
  A 2025 systematic review<sup><a href="#ref-1">1</a></sup> found that
  the recommended treatment protocol reduces complications by 47% in patients
  with Type 2 diabetes<sup><a href="#ref-2">2</a></sup>.
</p>

<section class="article-references">
  <h2>References</h2>
  <ol>
    <li id="ref-1">
      Smith J, Doe A, et al. (2025). "Treatment protocols for Type 2 diabetes: A systematic review."
      <em>New England Journal of Medicine</em>, 392(15), 1422-1438.
      <a href="https://pubmed.ncbi.nlm.nih.gov/{{PMID}}/" rel="noopener">PubMed</a>
      ·
      DOI: <a href="https://doi.org/{{DOI}}" rel="noopener">{{DOI}}</a>
    </li>
    <li id="ref-2">
      American Diabetes Association. (2026). "Standards of Medical Care in Diabetes — 2026."
      <em>Diabetes Care</em>, 49(Supplement 1).
      <a href="{{URL}}" rel="noopener">Full text</a>
    </li>
  </ol>
</section>

全屏观之 全屏出之

财事引据,当出SEC呈报、IRS刊行、FRED数据、联府研文;律事引据,当出首案法理、律法章条、规例章程。

五五五,增式于文章之体

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "MedicalWebPage",
  "headline": "{{TITLE}}",
  "author": {"@id": "https://{{PRIMARY_DOMAIN}}/authors/{{AUTHOR_SLUG}}/#person"},
  "reviewedBy": {"@id": "https://{{PRIMARY_DOMAIN}}/authors/{{REVIEWER_SLUG}}/#person"},
  "datePublished": "{{PUBLISHED_DATE}}",
  "dateModified": "{{UPDATED_DATE}}",
  "lastReviewed": "{{LAST_REVIEW_DATE}}",
  "publisher": {"@id": "https://{{PRIMARY_DOMAIN}}/#organization"},
  "specialty": {
    "@type": "MedicalSpecialty",
    "name": "{{MEDICAL_SPECIALTY}}"
  },
  "audience": {
    "@type": "MedicalAudience",
    "audienceType": "Patient"
  },
  "citation": {{ARTICLE_CITATIONS_JSON}},
  "isPartOf": {"@id": "https://{{PRIMARY_DOMAIN}}/#website"}
}
</script>

入全景模式 出全屏模式

法律文章,则用LegalServiceArticle详尽about属性。若为财经文章,则用Articlementions关涉者FinancialProduct实体。

五点五点六 评审者人模式(附加字段)

研评者需于 E-E-A-T 之常则外,更增《人》之架构详尽:

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Person",
  "@id": "https://{{PRIMARY_DOMAIN}}/authors/{{REVIEWER_SLUG}}/#person",
  "name": "{{REVIEWER_NAME}}",
  "jobTitle": "{{REVIEWER_TITLE}}",
  "honorificPrefix": "{{HONORIFIC_PREFIX}}",
  "honorificSuffix": "{{HONORIFIC_SUFFIX}}",
  "hasCredential": [
    {
      "@type": "EducationalOccupationalCredential",
      "name": "{{DEGREE_NAME}}",
      "credentialCategory": "degree",
      "recognizedBy": {
        "@type": "EducationalOrganization",
        "name": "{{INSTITUTION}}"
      }
    },
    {
      "@type": "EducationalOccupationalCredential",
      "name": "{{LICENSE_NAME}}",
      "credentialCategory": "license",
      "recognizedBy": {
        "@type": "GovernmentOrganization",
        "name": "{{LICENSING_BODY}}"
      },
      "identifier": "{{LICENSE_NUMBER}}",
      "url": "{{LICENSE_VERIFICATION_URL}}"
    }
  ],
  "memberOf": [
    {
      "@type": "Organization",
      "name": "{{PROFESSIONAL_ORG}}"
    }
  ],
  "knowsAbout": {{REVIEWER_SPECIALTIES_JSON}},
  "sameAs": {{REVIEWER_PROFILES_JSON}}
}
</script>

Enter fullscreen mode Exit fullscreen mode

5.6 阶六:心疾之危局应对

凡涉心疾之 YMYL 诸站,须显要且恒常置危线之助:

5.6.1 心疾危局之旌

于每一与心神相关之页展示之

<aside class="crisis-resources" role="note">
  <h2>If You're in Crisis</h2>
  <p>If you're experiencing thoughts of suicide or self-harm:</p>
  <ul>
    <li><strong>988 Suicide & Crisis Lifeline (US):</strong> Call or text <a href="tel:988">988</a></li>
    <li><strong>Crisis Text Line:</strong> Text HOME to <a href="sms:741741">741741</a></li>
    <li><strong>Veterans Crisis Line:</strong> Call <a href="tel:988">988</a> and press 1</li>
    <li><strong>International:</strong> <a href="https://www.iasp.info/resources/Crisis_Centres/" rel="noopener">Find a crisis center near you</a></li>
  </ul>
  <p>If you are in immediate danger, call <a href="tel:911">911</a> or go to your nearest emergency room.</p>
</aside>

入全景模式 出全屏模式

此幡现于至高关于心理健康之文,非在下也。

第七阶段:行业合规

五点七点一 医疗保健(适用HIPAA之实体)

倘若有hipaa_applicable: true

  • 隐私声明页
  • 隐私实践通知
  • 患者权利列举
  • 违规通知程序
  • 商业伙伴协议模板(供供应商使用)
  • 所有收集健康信息(PHI)的表格均使用HTTPS并配备适当加密
  • Cookie同意设置用于符合HIPAA要求的分析

5.7.2 金融服务

sec_registered: true:

  • 来自页脚链接的ADV表格
  • 可下载的简介(ADV表格第二部分A)
  • 伦理准则
  • 零售客户客户关系摘要(CRS表格)
  • 依据SEC规则的网络安全披露

finra_member: true:

  • 各代表经纪核查之链结
  • 投资者教育之资源
  • FINRA规则2210(广告)所要求之披露

5.7.3法律服务

各州律师广告合规:

  • "律师广告"或各州要求之等效标签
  • 各域之辞异,如纽约、佛罗里达、德克萨斯、加利福尼亚,皆有其别
  • 往昔之果辞
  • 律师会之必用言
  • 各州之专长申言限

5.8 阶第八:于 YMYL 之 AI 内容 — 更高之准

标准人工智能内容披露(E-E-A-T节4.4.6)不足于医疗健康领域。另有规程适用:

五点八一点 每篇文章的 YMYL 人工智能披露

<aside class="ymyl-ai-disclosure" role="note">
  <h3>How This Article Was Created</h3>
  <ul>
    <li>{{AI_USAGE_LEVEL}} — {{AI_USAGE_DESCRIPTION}}</li>
    <li>Reviewed for accuracy by {{REVIEWER_NAME}}, {{REVIEWER_CREDENTIALS}}</li>
    <li>All factual claims verified against primary sources cited in the references section</li>
    <li>{{REVIEW_DATE_AND_TIME_INVESTED}}</li>
  </ul>
  <p>See our <a href="/disclosure/">AI use policy</a> and <a href="/editorial-policy/">editorial policy</a> for details on our YMYL content standards.</p>
</aside>

入全景模式 出全屏模式

五点八二何者绝不可容于 YMYL

  • 人工智能所创之文,未经专家审阅而刊之
  • 由人工智能生成之医疗建议、诊断或治疗之推荐
  • 由人工智能生成之法律分析,呈示为权威
  • 由人工智能生成之财务建议
  • 由人工智能生成之案例研究或统计数据,非实
  • 人工智能伪造之引文(须独立核实每一引文)

若人工智能之器为 YMYL 之用而产文,视其出为研拟之草。持证之评者必核每事,每引,每荐。评者之名及资历附于文末——负其业责于文。

五九之期,更始历序

YMYL之文,需勤更迭,非YMYL者则不然。

药理类别 更新频率
药物信息、剂量、相互作用 月度
医疗病症治疗指南 季度
税务截止日期与税率 年度及监管变更时
投资产品评论 季度
法律程序指南 四时更迭 + 案例法之变
保险规制之导引 岁更于律令之变
新闻敏感之 YMYL (选举、公共卫生) 日日于活跃之时
常青之树 YMYL(解剖学,基础法律概念) 岁岁

建一更日历于/admin/ymyl-refresh-calendar/列每篇 YMYL 之文,附以复审之期.


6. 每页 YMYL 之验

每 YMYL 之页必过:

[#] 标准 严重性
Y1 文首之告示,关乎主题之横幅在焉 甚要
Y2 经认证作者署名 审慎
经认证审稿人署名(适用处须有可验证之执照) 审慎
最后发表、最后更新、最后审阅之日期皆须显示 审慎
若适用,须披露利益冲突 严苛
Y6 每项事实之引据须有原始文献 严苛
Y7 参考文献节列全源引证
Y8 专题特定之架构(如健康之MedicalWebPage)
Y9 审阅者之人格模式,含hasCredential之许可 要旨
Y10 危难资源示若论及心疾 要旨(心疾)
Y11 若涉AI创制则披露其用 要旨(若适用)
Y12 文内审阅及时,非陈腐之文

得分:24分满分。世界级优质内容文章:22+/24分,无重大缺陷。


七. 全站 YMYL 审计标准

超越篇目之标准,此域整体亦须合乎:

# 标准 严重性
YS1 編輯方針之頁在於/editorial-policy/
YS2 更正方針之頁在於/corrections-policy/
YS3 更正之錄維持於/corrections-log/
YS4 特定主題之免責聲明頁存有(醫療、財務、法律依適用)
YS5 作者页列有持证者,其执照可查
YS6 研物之存与分类,内中详载
YS7 历日更新,附注复审之期
YS8 行业合规文件备齐(HIPAA、SEC、律师广告) 要则(若适用)
YS9 Cookie同意调适于行业合规 要则(若HIPAA/金融)
YS10 危机资源显于全站心理健康页 要则(心理健康)
逸山十一 人工智能使用规范明文规定,与用户利益密切相关的领域内容标准
YS12 每季内 YMYL 审计已进行并记录 中道

得分:24分(满分)。世界级YMYL网站:22+/24分,无重大失误。


八、常犯之 YMYL 误失& 反模式

8.1 "教育"之内容实为劝谏

反模式: 伪称"教育"之文,实导读者就某事决断("此药最宜..."、"当投资...")。此"教育"之饰,乃劝谏之障也.

何以不效:谷歌之评者察之,监管之体察之。读者因循默示之害,有法理之诉。

:修正:或恪守建言(具资格之署名与正当之披露),或专于教化(以明晰之辞,非为指令)。

8.2 泛评审者之钤印

:非道之范:一"医者评者"之名,列于百篇之文,然无实据证其曾一一评阅之。

何以败之:既察(常由诸文之论不一而见),则全站之信立崩。

其治:评者之制必真。踪迹各评者所实评之文,存核验之迹。

8.3 旧式 YMYL 之文视作新式

反常之式:载于二零二一年之文论“现行税法”犹居高位而不更新。

其败之由:陈腐之 YMYL 伤及众,核心更新后排名骤降。

其治之策:频速更新。废弃不可持继之文。

8.4 YMYL中隐匿之联盟冲突

反模式:医病之网荐补剂;联盟披露见于页脚,然不见于文内。

其败之由:FTC要求“明晰昭著”之披露。尤以YMYL为甚,其冲突实要。

其治之策:凡附有推广链接之 YMYL 文章,须于篇首明示之。

8.5:以个人琐事为普适之训

反常之式:"吾以是术愈焦虑" 伪为普适之方,欲效读者。

其败之由:心神之疾,殊异万殊。泛引己验,实为戕害。

:将个人经历视作己身之事。明示声明,此经历未必适用于他人.

8.6 生成之AI,无真审之YMYL

反常之式:ChatGPT撰文,论药石之副作用。无资之编者"审"之。行文为权威之论.

其败何在:智械幻象于专业内容,可直伤阅者。无认证审核,乃失信之过。检测之率日增。

:或不用智械草拟专业文,或使认证专家实核每事引据。

8.7 陈腐免责语不协内容

反常之式:凡文末所附"宜咨专业人士"之警示,明示读者当何为.

其何以不效:警示不能使指令性内容免责。况监管者不纳陈腐警示为护身符.

其解:须使警示之辞与内容相合。若所陈者乃忠告,则警示当显忠告之旨。若所授者乃教化,则内容当具教化之实。

8.8 虚假之资历声称

反常之范式:作者小传称"二十载之经验",然未明言其业。或列资历简称,似有可观,实则无涉(如非医之"博士"评医道内容)。

:何以败之:资历惑人,既发则违信。加之:医、法、财之业,或为非法。

:其方:确凿可考之凭信。以平实之言,释此人之凭信何以与论题相关。

8.9 虚构引证

反常之式:文引一不存在之研究,或歪曲研究所得。常发生于人工智能所生之文。

其败之由: 易验。既发,则信义崩坏,祸不旋踵。

修之: 诸引文必当独立核验,方得刊布。悉点诸链接。亲览其本源。

八点一零,越境之 YMYL 而无疆域之识

反模式美利坚法律之文,为异邦读者所观,然其遵循之导,非适此也。

何故败之:害于国际读者。思其站之质

:治之:明其管辖之域。国际读者,或导至适国资源


9. 堆栈专有之YMYL施行要言

YMYL之文,可于任堆栈创制管理,然此法助之:

9.1 WordPress

  • 插件:以定制插件或ACF(高级自定义字段)为用,于每篇文章增补专于YMYL之字段:评审者、许可证号、末次评审之期、利益冲突之披露
  • 模板:构建专司ymyl-article.php之模板,以呈示所需之免责声明+评审者之区块+引文之要求
  • 工作之流程:用編輯日曆或PublishPress以強制審閱者指派,方得發表

9.2 Next.js

  • 內容模式:定 TypeScript 類型於 YMYL 文章前文,需審閱者、許可證、引文陣列
  • 驗證:發表前CI/CD步驟驗證 YMYL 必須字段俱在
  • 組件<YmylArticleHeader />之组件,裹含免责声明及作者/审阅者之署名、日期

9.3 星图/鸿鹄/静态之站

  • 内容之集:定义有关于重要健康相关文章之架构,列明必具之字段
  • 构建时之验证:拒斥构建,若重要健康相关文章缺漏必具之字段
  • 版式:专精于 YMYL 之文,其布局必严守结构之规

9.4 通式

无论堆叠,其 YMYL 之流程若此:

  1. 作者撰文,附 YMYL 分类之元数据
  2. 稿成,送至有资之审者
  3. 审者加注评语,并署日以结
  4. 编者核验,依本源查证
  5. 刊发之制,须具所有 YMYL 项目,方得问世
  6. 文章显,具 YMYL 之信要素备矣
  7. 更历日,追次审之期
  8. 季审,验 YMYL 之文皆合制

10. 引 14 层之纲

医理实施涉数层:

  • 第一层单点登录:HIPAA合规健康之域需安。
  • 第一层通用控制:GDPR/CCPA合规与医疗/财会隐私之需相叠。
  • 第二层编辑信任信号:每文可信之迹(免责声明、评审者之誉)。
  • 第二层访问控制。:著者之权柄——延展于持证之 YMYL 著者
  • 四级 PBO:个人之品牌于持证之评论者
  • 四级 REO:评论于 YMYL 之领域,权重愈重
  • 六级 RSO:研索与原创之研究——主要文献之引证
  • :八级 GA4:合乎法规之分析,用于专业健康信息网站

:若专业健康信息网站之改良为要务,则当依序施行:

  1. :分类其内容(第五篇第一节)
  2. :立编辑与更正之章程(第五篇第二节至第三节)
  3. :立专题免责之章程(第五篇第四节)
  4. 招募持证评者若未既立
  5. 篇篇有 YMYL 要素(第五五节)
  6. 行业合规文书(第五十七章)
  7. 更新日历(第五节第九条)
  8. 若适用,则提供心理健康危机资源(第五六章)

十一、验证之仪

十一·一 自动验证

# Verify all YMYL articles have required schema
for url in $YMYL_URLS; do
  curl -sL "$url" | python -c "
import sys, re, json
html = sys.stdin.read()
matches = re.findall(r'<script type=\"application/ld\+json\">(.*?)</script>', html, re.DOTALL)
has_reviewer = False
for m in matches:
    try:
        data = json.loads(m)
        if 'reviewedBy' in data:
            has_reviewer = True
    except:
        pass
if not has_reviewer:
    print(f'{url}: MISSING reviewedBy')
    sys.exit(1)
"
done

Enter fullscreen mode Exit fullscreen mode

# Verify all YMYL articles have disclaimer
for url in $YMYL_URLS; do
  if ! curl -sL "$url" | grep -q 'class="ymyl-top-disclaimer"'; then
    echo "FAIL: $url missing disclaimer"
  fi
done

Enter fullscreen mode Exit fullscreen mode

# Verify required pages
REQUIRED=(/editorial-policy/ /corrections-policy/ /corrections-log/)
for page in "${REQUIRED[@]}"; do
  status=$(curl -o /dev/null -s -w "%{http_code}" "https://$DOMAIN$page")
  [ "$status" != "200" ] && echo "FAIL: $page returned $status"
done

Enter fullscreen mode Exit fullscreen mode

十一·二 手工验证

  • 取十之一于医理文章,核其六节之要素悉备.
  • 核审者之资,检其执照验证之途.
  • 抽查引文——遍点所引文章之参考节之链接。核其源实存且证其言.
  • 试心理健康之急难资源可见,且链接可用。
  • 审察智造昭示,若于诸般要害之文,用智造则须昭示之.

11.3 法规之验

  • HIPAA所涉之体:岁须HIPAA之官察其地.
  • SEC所登之肆:季须合规之官察其宣.
  • 律所:须主事之伴察诸州律师宣之合.__JHSNS_SEG_8a142a71_547__
  • 理财顾问:须合规官依 FINRA 规则 2210 审阅之

12. 审计之式

用第 4.1 节以分类每项内容。继而依:

  • 每文之标准(第 6 节)— 每文至多 24 分。遍平均诸 YMYL 文章之分数
  • 全站之标准(第 7 节)— 至多 24 分。

至多48分,以评YMYL之审。

得分数 状态
44-48 世界级YMYL合规
38-43 略有不足,尚合于规
30-37 有重大不足,需整改之
<30 要害之失,亟需速行

一地之合规,非要害失皆可,纵总得犹然


13. 修持之序

13.1 日修

  • 若涉心疾之页,须察其真伪
  • 更正之请,须于两日之内应之

每周

  • 检视更新队列中一篇 YMYL 内容
  • 查寻新引文以增补(新研究、法规更新)

  • 每月
  • 生成 YMYL 合规状态报告
  • 更正记录,录所修正之材料 __JHSNS_SEG_8a142a71_578__ 运行自动化 YMYL 验证,遍及所有标记内容
  • 更新时效性内容(药品信息、税期等)

13.4 季度

  • 对随机抽样的10%的YM内容进行全面审计
  • 审阅者资质验证(执照仍在有效期内,未被吊销)
  • 编辑政策审查
  • 行业合规审计(HIPAA、SEC、律师广告)
  • 更新日历以纳新内容

13.5 每岁一更

  • 遍察全网之 YMYL 审计
  • 编审方针重审
  • 免责声明法理检视
  • 人工智能应用政策检视
  • 评审团察核(凡变改、增补、去取)
  • 谋略之决:吾等犹可负责任乎,以发乎 YMYL 之文?

13.6 法令之变

  • 新 SEC/FINRA 之规 → 财经之文审于三十日
  • 新税法 → 税文立审
  • 新医道之则(ADA 标准与 ACOG 指南等)→ 相关之文审于六十日
  • 廷议所涉律令之变,九十日当察之

十四、实施/审计报告模板

十四·一 依美雅兰实施报告范本

# YMYL Framework Implementation Report

**Project**: {{BUSINESS_NAME}}
**Domain**: {{PRIMARY_DOMAIN}}
**Implementation Date**: {{TODAY}}
**YMYL Classification**: {{CLASSIFICATION}}
**YMYL Categories**: {{CATEGORIES}}

## Summary
- **Total YMYL articles**: {{COUNT}}
- **Articles with full YMYL trust elements**: {{COUNT}}
- **Critical items remediated**: {{COUNT}}
- **Reviewer team established**: {{REVIEWER_LIST}}

## Required Pages Created
- /editorial-policy/ — {{STATUS}}
- /corrections-policy/ — {{STATUS}}
- /corrections-log/ — {{STATUS}}
- /medical-disclaimer/ — {{STATUS}}
- /financial-disclaimer/ — {{STATUS}}
- /legal-disclaimer/ — {{STATUS}}

## Per-Article Trust Elements Installed
{{TABLE_OF_ARTICLES_WITH_INSTALLED_ELEMENTS}}

## Industry Compliance Documentation
{{LIST_OF_COMPLIANCE_DOCS}}

## Items Flagged for Manual Review
{{LIST_WITH_REASONS}}

## Refresh Calendar Established
- Articles requiring monthly refresh: {{COUNT}}
- Articles requiring quarterly refresh: {{COUNT}}
- Articles requiring annual refresh: {{COUNT}}

## Validation Results
{{AUTOMATED_AND_MANUAL_RESULTS}}

## Sign-Off
Implementation complete: {{DATE}}
Implementer: {{NAME}}
Editorial Lead: {{NAME}}
Compliance Lead: {{NAME}}

入全景模式 出全屏模式

十四有二,宜民有良之检报式

# YMYL Framework Audit Report

**Site**: {{BUSINESS_NAME}}
**Audit Date**: {{TODAY}}
**YMYL Classification**: {{CLASSIFICATION}}

## Executive Summary
{{SUMMARY}}

**Overall Score**: {{X}}/48 ({{PERCENTAGE}}%)
**Status**: {{STATUS}}

## YMYL Inventory
- Total content: {{COUNT}}
- YMYL content (full): {{COUNT}}
- YMYL content (partial): {{COUNT}}
- YMYL content (lite): {{COUNT}}
- Non-YMYL content: {{COUNT}}

## Per-Article Compliance ({{X}}/24 average)
{{DETAILED_PER_ARTICLE_FINDINGS}}

## Site-Wide Compliance ({{X}}/24)
{{DETAILED_SITE_FINDINGS}}

## Critical Failures
{{LIST_WITH_REMEDIATION}}

## High-Severity Issues
{{LIST_WITH_REMEDIATION}}

## Industry-Specific Findings
{{HIPAA_SEC_BAR_FINDINGS}}

## Recommended Remediation Order
{{PRIORITIZED_LIST}}

## Sign-Off
Audit complete: {{DATE}}
Auditor: {{NAME}}

入全景模式 出全屏模式


框架文书终

文書版本
末次更新二〇二六年四月廿九日
由之维护那位开发者

《易简录》乃基库之重器。其文有误,则损于众,引法理之责,致位阶骤降。此文书之规,不可稍易。倘有疑虑,当趋严苛——增警示,延审者,频更新,慎立言。

此库同文:

  • framework-eeat.md — 基础之 E-E-A-T(YMYL 适用更高之 E-E-A-T 标准)
  • framework-hcs.md — 有益之内容系统
  • framework-sqrg.md — 搜索质量评审指南
  • framework-coreupdates.md — 核心更新
  • framework-infogain.md — 信息增益
  • framework-entitysalience.md — 实体显著性
  • framework-knowledgegraph.md — 知识图谱
  • framework-aicitations.md — 人工智能引证理论

有关此框架库

此文乃ThatDevPro之SEO+AI工程库中框架参考文档,于Dev.to再刊。正源https://www.thatdevpro.com/insights/framework-ymyl/

ThatDevPro乃SDVOSB认证之退役军人创办之网络与人工智能工程工作室,设于密苏里州卡西维尔。该工作室运营全十四级引擎优化 堆栈与航船开源之器,用于人工智能引文之工.

伴行十四级引擎优化之堆栈 (每级皆为独立之文):

  1. 第一级 — 基础
  2. 第二级 — 搜索显见
  3. 第三级 — 人工智能之统御
  4. 第四级 — 实体与权威
  5. 第五级 — 地域之统御
  6. 六级——内容与多媒体
  7. 七级——社交与社群
  8. 八级——数据、分析、转化
  9. 九级——监控与智能
  10. 十级——流程与运营
  11. 十一级——市场与零售
  12. 十二级——国际
  13. 十四级——高级与沉浸

需此框架施于尔之网站乎?观引擎优化之务或雇之那开发者联系.